Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Alentis and PinotBio partner to develop claudin-1 oncology ADCs
The joint initiative aims to apply PinotBio’s platform technologies to Alentis’ antibody assets to address claudin-1. Credit: THICHA SATAPITANON/Shutterstock.com.
The joint initiative aims to apply PinotBio’s platform technologies to Alentis’ antibody assets to address claudin-1. Credit: THICHA SATAPITANON/Shutterstock.com.